By Joel Barthelemy – Prior to COVID-19 there was difficulty in meeting the global demand for healthcare workers. But as COVID-19 cases surge around the world and across America, we are facing an increased shortage of doctors, nurses, hospital beds, as well as…
Read More
In this Special Coronavirus Edition we have news from GlobalMed, American Telemedicine Association, Amwell, Bluestream, CirrusMD, Kareo, KNB Communications, Teledaddy and more.
The FCC’s Wireline Competition Bureau approved six funding applications for the COVID-19 Telehealth Program. Health care providers in some of the hardest hit areas like New York will use this $3.23 million in funding to provide telehealth services during the coronavirus pandemic.
By Peyman Zand – The arrival of the coronavirus pandemic and social distancing measures has ensured that telemedicine is here to stay. Hospitals and clinics are enabling telehealth visits to their providers as quickly as possible.
By Matt Fisher – As the telehealth flood gates are being opened, privacy and security considerations still remain. HIPAA will continue to lurk in the background even with the OCR pre-announcing the exercise of discretion to not enforce telehealth related violations during the COVID-19 pandemic.
The Federal Communications Commission voted to adopt a $200 million telehealth program to support healthcare providers responding to the ongoing coronavirus pandemic. Congress appropriated the funds as part of the CARES Act.
By Luke Kistler – Telemedicine reimbursement is a notoriously complex topic. Policies tend to vary between states, payers, procedure codes and other factors; a variety of myths and misperceptions can complicate virtual health strategy even more.
In this Special Coronavirus Edition we have news from GlobalMed, Rhinogram Telehealth, American Well, Teladoc Health, MobileSmith Health, American Telemedicine Association, Atrium Health, VitalTech, Carbon Health and more.
By Matt Fisher – The declaration of COVID19 as a pandemic and the United States declaring a national emergency to help contain and enhance treatment access have resulted in a number of changes to ease potential regulatory burdens or barriers in healthcare.